Provision of a New Antimicrobial to the NHS in England

About

NHS England awarded a contract to Shionogi for the supply of a new antimicrobial to the NHS in England.

The procurement required participants to have at least one EU-licensed antimicrobial with a UK launch date between 1 January 2020 and 31 December 2020, active against one or more pathogens on the World Health Organisation priority pathogen list.

The contract is for use by the Department of Health and Social Care, Public Health England, the NHS in England, and private sector healthcare contractors and agents working on behalf of these entities.

Shionogi will be responsible for supply from 1 July 2022.

The contract duration is an initial three years, with an option to extend by mutual agreement for up to an additional seven years.

The contract value is broadly commensurate with the advertised value of £100 million, though the exact value cannot be published for confidentiality reasons.